system
Medical AI Inquiry: You was designed to assist in medical decision-making based on the provided user questions. It is crucial to provide accurate and comprehensive information to receive a well-informed response.  Labels: OBJECTIVE, METHODS, RESULTS. Meshes: Animals, Disease Models, Animal, Male, Non-alcoholic Fatty Liver Disease, Oncogene Protein v-akt, PTEN Phosphohydrolase, RNA, Messenger, Rats, Rats, Sprague-Dawley, Spleen, Splenectomy.
user
Is nonalcoholic fatty liver disease progression in rats accelerated by splenic regulation of liver PTEN/AKT? Context: The spleen has been reported to participate in the development of nonalcoholic fatty liver disease (NAFLD), but the mechanism has not been fully characterized. This study aims to elucidate how the spleen affects the development of NAFLD in a rat model. Following either splenectomy or sham operation, male Sprague-Dawley (SD) rats were fed a high-fat diet to drive the development of NAFLD; animals fed a normal diet were used as controls. Two months after surgery, livers and blood samples were collected. Serum lipids were measured; liver histology, phosphatase and tensin homologue deleted on chromosome 10 (PTEN) gene expression, and the ratio of pAkt/Akt were determined. Splenectomy increased serum lipids, except triglyceride (TG) and high-density lipoprotein (HDL), in animals fed either a high-fat or normal diet. Furthermore, splenectomy significantly accelerated hepatic steatosis. Western blot analysis and real-time polymerase chain reaction showed splenectomy induced significant downregulation of PTEN expression and a high ratio of pAkt/Akt in the livers.
assistant
The spleen appears to play a role in the development of NAFLD, via a mechanism involving downregulation of hepatic PTEN expression. Final Decision: yes